Mitochondrial quality control in kidney injury and repair

C Tang, J Cai, XM Yin, JM Weinberg… - Nature Reviews …, 2021 - nature.com
Mitochondria are essential for the activity, function and viability of eukaryotic cells and
mitochondrial dysfunction is involved in the pathogenesis of acute kidney injury (AKI) and …

Pharmacotherapy of type 2 diabetes: An update and future directions

A DeMarsilis, N Reddy, C Boutari, A Filippaios… - Metabolism, 2022 - Elsevier
Abstract Type 2 diabetes (T2D) is a widely prevalent disease with substantial economic and
social impact for which multiple conventional and novel pharmacotherapies are currently …

Diabetic kidney disease

MC Thomas, M Brownlee, K Susztak… - Nature reviews Disease …, 2015 - nature.com
The kidney is arguably the most important target of microvascular damage in diabetes. A
substantial proportion of individuals with diabetes will develop kidney disease owing to their …

Thiazolidinediones as antidiabetic agents: A critical review

MJ Nanjan, M Mohammed, BRP Kumar… - Bioorganic …, 2018 - Elsevier
Abstract Thiazolidinediones (TZDs) or Glitazones are an important class of insulin
sensitizers used in the treatment of Type 2 diabetes mellitus (T2DM). TZDs were reported for …

The impact of insulin resistance on the kidney and vasculature

F Artunc, E Schleicher, C Weigert, A Fritsche… - Nature Reviews …, 2016 - nature.com
Insulin resistance is a systemic disorder that affects many organs and insulin-regulated
pathways. The disorder is characterized by a reduced action of insulin despite increased …

Mitochondrial dysfunction in the pathophysiology of renal diseases

R Che, Y Yuan, S Huang… - American Journal of …, 2014 - journals.physiology.org
Mitochondrial dysfunction has gained recognition as a contributing factor in many diseases.
The kidney is a kind of organ with high energy demand, rich in mitochondria. As such …

Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair

W Cai, T Yang, H Liu, L Han, K Zhang, X Hu… - Progress in …, 2018 - Elsevier
Peroxisome proliferator-activated receptor γ (PPARγ) is a widely expressed ligand-
modulated transcription factor that governs the expression of genes involved in …

Obesity‐related glomerulopathy: Current approaches and future perspectives

JI Martínez‐Montoro, E Morales… - Obesity …, 2022 - Wiley Online Library
Obesity‐related glomerulopathy (ORG) is a silent comorbidity which is increasing in
incidence as the obesity epidemic escalates. ORG is associated with serious health …

Acute kidney injury and progression of diabetic kidney disease

SMW Yu, JV Bonventre - Advances in chronic kidney disease, 2018 - Elsevier
Diabetic kidney disease, commonly termed diabetic nephropathy (DN), is the most common
cause of end-stage kidney disease (ESKD) worldwide. The characteristic histopathology of …

Fatty liver and chronic kidney disease: novel mechanistic insights and therapeutic opportunities

G Musso, M Cassader, S Cohney, F De Michieli… - Diabetes …, 2016 - Am Diabetes Assoc
Chronic kidney disease (CKD) is a risk factor for end-stage renal disease (ESRD) and
cardiovascular disease (CVD). ESRD or CVD develop in a substantial proportion of patients …